Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Abemaciclib/palbociclib

Treatment failure and grade 2 diarrhoea: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fenchel K, et al. Single center experience with Abemaciclib Administration in unfavourable relapsed breast cancer patients with progression after Palbociclib. Oncology Research and Treatment 43 (Suppl. 4): 165-166 abstr. 689, Oct 2020. Available from: URL: http://doi.org/10.1159/000510995 [abstract] Fenchel K, et al. Single center experience with Abemaciclib Administration in unfavourable relapsed breast cancer patients with progression after Palbociclib. Oncology Research and Treatment 43 (Suppl. 4): 165-166 abstr. 689, Oct 2020. Available from: URL: http://​doi.​org/​10.​1159/​000510995 [abstract]
Metadaten
Titel
Abemaciclib/palbociclib
Treatment failure and grade 2 diarrhoea: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-32900-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Finasteride

Case report

Prednisone